Eve Bender June 14, 2023 Intranasal (IN) ketamine may be a feasible treatment alternative for people with chronic, refractory migraine who don’t respond to other medications, new research shows. Half of the study participants who used IN ketamine for chronic, treatment- refractory migraine in a new retrospective cohort study reported it as “very effective” and over one third said it boosted...
Tag: <span>Intranasal Ketamine</span>
Post
IV vs Intranasal Ketamine: Which is Best?
Megan Brooks May 30, 2023 Intravenous ketamine and intranasal esketamine are both equally effective in improving symptoms of treatment-resistant depression (TRD) in adults, but “speed and cost” appear to favor IV ketamine in clinical practice, results of an observational, single-center study show. Because of insurance restrictions on esketamine nasal spray, treatment initiation can take several weeks longer than IV...
Post
Faster Response to IV vs Intranasal Ketamine in Depression
Nancy A. Melville May 26, 2022 NEW ORLEANS – New research reveals that patients with treatment-resistant depression who were treated with repeated intravenous ketamine show no significant differences in achieving response or remission, compared with those receiving the intranasal formulation of the drug, esketamine – although fewer treatments appear necessary with the intravenous formulation. Dr Balwinder Singh...
Post
Intranasal Ketamine Effective in Cluster Headache
Steve Cimino January 20, 2022 Intranasal ketamine may be a viable treatment option for acute cluster headache attacks, a pilot study has found, though it did not reduce pain intensity as quickly as initially anticipated. “In clinical practice, intranasal ketamine might be a valuable tool for severely affected patients with insufficient response or intolerance to current first-line treatment,” wrote Anja...